A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
ImmuneOncia Therapeutics Inc.
ImmuneOncia Therapeutics Inc.
Sun Yat-sen University
Dren Bio
Thomas Jefferson University
National Cancer Institute (NCI)
Beijing Tongren Hospital
International Extranodal Lymphoma Study Group (IELSG)
Bristol-Myers Squibb
Fudan University